These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3875751)

  • 1. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity.
    Shu S; Fonseca LS; Kato H; Zbar B
    Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.
    Shu S; Steerenberg PA; Hunter JT; Evans CH; Rapp HJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3499-506. PubMed ID: 7260913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity.
    Shu S; Hunter JT; Rapp HJ; Fonseca LS
    J Natl Cancer Inst; 1982 Apr; 68(4):673-80. PubMed ID: 6951081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of immunological eradication of a syngeneic guinea pig tumor. II. Effect of methotrexate treatment and T cell depletion of the recipient on adoptive immunity.
    Shu S; Fonseca LS; Hunter JT; Rapp HJ
    Transplantation; 1983 Jan; 35(1):56-61. PubMed ID: 6297130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of experimental allergic orchitis. III. T lymphocyte requirement in local adoptive transfer by peritoneal exudate cells.
    Tung KS; Leong C; McCarty T
    J Immunol; 1977 May; 118(5):1774-9. PubMed ID: 300759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
    Janeway CA
    J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells.
    Doyle MV; Parks E; Weigle WO
    J Immunol; 1976 Oct; 117(4):1152-8. PubMed ID: 61992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells.
    Roska AK; Johnson AR; Lipsky PE
    J Immunol; 1984 Jan; 132(1):136-45. PubMed ID: 6197441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against experimental toxoplasmosis by adoptive immunotherapy.
    Pavia CS
    J Immunol; 1986 Nov; 137(9):2985-90. PubMed ID: 3489780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.